Λίστα αντικειμένων
According to bibliography, G-CSF administration on day -1, 8 or during febrile neutropenia is not relevant with the progression of the disease. In contrast, G-CSF administration reduces TRM and can accelerate ANC recovery.
As a result, we decided to administer G-CSF from day 15 (from the beggining of the induction chemotherapy).
Presenter:Dr Katsaouni
Participants: Prof.Spyridonidis, Dr Liga, Dr Spyridis, Dr Lekka, Dr Verigou